Kilitch Drugs (India) Statistics
Total Valuation
BOM:524500 has a market cap or net worth of INR 5.10 billion. The enterprise value is 5.05 billion.
| Market Cap | 5.10B |
| Enterprise Value | 5.05B |
Important Dates
The next estimated earnings date is Saturday, February 14, 2026.
| Earnings Date | Feb 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:524500 has 16.08 million shares outstanding. The number of shares has increased by 1.40% in one year.
| Current Share Class | 16.08M |
| Shares Outstanding | 16.08M |
| Shares Change (YoY) | +1.40% |
| Shares Change (QoQ) | +2.38% |
| Owned by Insiders (%) | 34.79% |
| Owned by Institutions (%) | n/a |
| Float | 3.41M |
Valuation Ratios
The trailing PE ratio is 18.42.
| PE Ratio | 18.42 |
| Forward PE | n/a |
| PS Ratio | 2.44 |
| PB Ratio | 1.93 |
| P/TBV Ratio | 2.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 59.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.84, with an EV/FCF ratio of -7.12.
| EV / Earnings | 18.08 |
| EV / Sales | 2.41 |
| EV / EBITDA | 15.84 |
| EV / EBIT | 17.13 |
| EV / FCF | -7.12 |
Financial Position
The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.53 |
| Quick Ratio | 2.17 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 2.62 |
| Debt / FCF | -1.18 |
| Interest Coverage | 4.94 |
Financial Efficiency
Return on equity (ROE) is 11.72% and return on invested capital (ROIC) is 9.81%.
| Return on Equity (ROE) | 11.72% |
| Return on Assets (ROA) | 5.60% |
| Return on Invested Capital (ROIC) | 9.81% |
| Return on Capital Employed (ROCE) | 9.34% |
| Weighted Average Cost of Capital (WACC) | 3.63% |
| Revenue Per Employee | 11.20M |
| Profits Per Employee | 1.50M |
| Employee Count | 187 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 12.49 |
Taxes
In the past 12 months, BOM:524500 has paid 88.07 million in taxes.
| Income Tax | 88.07M |
| Effective Tax Rate | 24.93% |
Stock Price Statistics
The stock price has decreased by -0.45% in the last 52 weeks. The beta is -0.16, so BOM:524500's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | -0.45% |
| 50-Day Moving Average | 345.64 |
| 200-Day Moving Average | 387.96 |
| Relative Strength Index (RSI) | 32.87 |
| Average Volume (20 Days) | 731 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524500 had revenue of INR 2.09 billion and earned 279.59 million in profits. Earnings per share was 17.23.
| Revenue | 2.09B |
| Gross Profit | 961.74M |
| Operating Income | 295.01M |
| Pretax Income | 353.25M |
| Net Income | 279.59M |
| EBITDA | 319.10M |
| EBIT | 295.01M |
| Earnings Per Share (EPS) | 17.23 |
Balance Sheet
The company has 869.99 million in cash and 836.13 million in debt, with a net cash position of 33.87 million or 2.11 per share.
| Cash & Cash Equivalents | 869.99M |
| Total Debt | 836.13M |
| Net Cash | 33.87M |
| Net Cash Per Share | 2.11 |
| Equity (Book Value) | 2.64B |
| Book Value Per Share | 161.22 |
| Working Capital | 1.26B |
Cash Flow
In the last 12 months, operating cash flow was 86.06 million and capital expenditures -796.03 million, giving a free cash flow of -709.97 million.
| Operating Cash Flow | 86.06M |
| Capital Expenditures | -796.03M |
| Free Cash Flow | -709.97M |
| FCF Per Share | -44.15 |
Margins
Gross margin is 45.92%, with operating and profit margins of 14.08% and 13.35%.
| Gross Margin | 45.92% |
| Operating Margin | 14.08% |
| Pretax Margin | 16.87% |
| Profit Margin | 13.35% |
| EBITDA Margin | 15.23% |
| EBIT Margin | 14.08% |
| FCF Margin | n/a |
Dividends & Yields
BOM:524500 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.40% |
| Shareholder Yield | -1.40% |
| Earnings Yield | 5.48% |
| FCF Yield | -13.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |